Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis.

Danny RischinNikhil I KhushalaniChrysalyne D SchmultsAlexander D GuminskiAnne Lynn S ChangKarl D LewisAnnette M LimLeonel Hernandez-AyaBrett G M HughesDirk SchadendorfAxel HauschildAlesha A ThaiElizabeth StankevichJocelyn BoothSuk-Young YooSiyu LiZhen ChenEmmanuel OkoyeChieh-I ChenVera MasteyMedha SasaneIsrael LowyMatthew G FuryMichael R Migden

Published in: Journal for immunotherapy of cancer (2022)

ClinicalTrials.gov Registry (NCT02760498), https://clinicaltrialsgov/ct2/show/NCT02760498.

Keyphrases

squamous cell carcinoma
open label
randomized controlled trial
lymph node metastasis
clinical trial
magnetic resonance
radiation therapy
double blind
placebo controlled
pet ct
glycemic control